Health Care: Drugs

Emergent BioSolutions Inc (EBS: NYSE)

$21.37 -0.32 | -1.48%
09/30/14 - 10:06 AM ET
Company Profile
Price and Volume
Recent Price 21.69
52 Week High 28.48
52 Week Low 17.31
Avg. Daily Vol. (Mil) 0.21
Beta (3 year) 1.19
Share Related Items
Mkt Cap (Mil) 812.88
Shares Out (Mil) 37.48
Float (Mil) 29.13
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.40
Current Ratio 4.50
LT Debt/ Equity 0.51
Total Debt / Equity 0.51
Valuation Ratios
Price Earnings 60.60
Price/Sales 2.31
Price/Book 1.67
Price/Cash Flow 20.60
Per Share Data
Earnings 0.36
Sales 9.38
Book Value 13.02
Cash Flow 1.05
Business Summary
Emergent BioSolutions, Inc., is a biopharmaceutical company, which is engaged in the development, manufacture and commercialization of vaccine and immune-related therapeutic that assist the body's immune system to prevent or treat disease.
General Information
2273 Research Boulevard
Suite 400
Rockville, MD 20850
www.emergentbiosolutions.com
Industry : Drugs
Sector: Health Care
Employees: 1353
CEO: Daniel J. Abdun-Nabi
Short Interest
Current Month (Mil) 3.77
Previous Month (Mil) 3.73
Short Interest Ratio (Days) 17.40
Management Effectiveness
Return on Equity 2.80
Return on Assets 1.60
Return on Investments 1.80
Profitability
Gross Margin 80.90
EBIT Margin 7.50
Profit Margin 3.80

Portfolios with EBS

Latest EBS Headlines from TheStreet

More Financial News for EBS

Press Releases for EBS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter